High mortality and low access to care following incident acute myocardial infarction in individuals with schizophrenia

Schizophrenia Research

Volumn 142, Issue 1-3, 2012, Pages 52-57

  Kurdyak, Paul ^a,b,c   Vigod, Simone ^c,d   Calzavara, Andrew ^b   Wodchis, Walter P ^b,c  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c Institute for Health Policy   (Canada)

^d WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

Acute myocardial infarction; Mortality; Schizophrenia

Indexed keywords

ACUTE HEART INFARCTION; AGED; ARTICLE; CANADA; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH CARE ACCESS; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHIZOPHRENIA;

AGED; AGED, 80 AND OVER; ALGORITHMS; ANALYSIS OF VARIANCE; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ONTARIO; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SURVIVAL ANALYSIS;

EID: 84869885695     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.09.003     Document Type: Article

References (38)

1. Austin P., Daly P., Tu J. A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. Am. Heart J. 2002, 144(2):290-296.
2. Austin P.C., van Walraven C., Wodchis W.P., Newman A., Anderson G.M. Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a general adult population cohort in Ontario, Canada. Med. Care 2011, 49(10):932-939.
3. Austin P.C., Newman A., Kurdyak P.A. Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a population-based cohort of adults with schizophrenia in Ontario, Canada. Psychiatry Res. 2012, 196(1):32-37.
4. Ayanian J.Z., Landrum M.B., Guadagnoli E., Gaccione P. Specialty of ambulatory care physicians and mortality among elderly patients after myocardial infarction. N. Engl. J. Med. 2002, 347(21):1678-1686.
5. Becker T., Hux J. Risk of acute complications of diabetes among people with schizophrenia in Ontario, Canada. Diabetes Care 2011, 34(2):398-402.
6. Bell R.C., Farmer S., Ries R., Srebnik D. Metabolic risk factors among medicaid outpatients with schizophrenia receiving second-generation antipsychotics. Psychiatr. Serv. 2009, 60(12):1686-1689.
7. Brown S., Kim M., Mitchell C., Inskip H. Twenty-five year mortality of a community cohort with schizophrenia. Br. J. Psychiatry 2010, 196(2):116-121.
8. Colton C., Manderscheld R. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev. Chronic Dis. 2006, 3(2):A42.
9. Daumit G.L., Goff D.C., Meyer J.M., Davis V.G., Nasrallah H.A., McEvoy J.P., Rosenheck R., Davis S.M., Hsiao J.K., Stroup T.S., Lieberman J.A. Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study. Schizophr. Res. 2008, 105(1-3):175-187.
10. De Hert M., Dekker J.M., Wood D., Kahl K.G., Holt R.I., Moller H.J. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur. Psychiatry 2009, 24(6):412-424.
11. de Leon J., Diaz F.J. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr. Res. 2005, 76(2-3):135-157.
12. Druss B.G., Bornemann T.H. Improving health and health care for persons with serious mental illness: the window for US federal policy change. JAMA 2010, 303(19):1972-1973.
13. Druss B.G., Bradford D.W., Rosenheck R.A., Radford M.J., Krumholz H.M. Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA 2000, 283(4):506-511.
14. Enger C., Weatherby L., Reynolds R.F., Glasser D.B., Walker A.M. Serious cardiovascular events and mortality among patients with schizophrenia. J. Nerv. Ment. Dis. 2004, 192(1):19-27.
15. Gershon A.S., Wang C., Guan J., Vasilevska-Ristovska J., Cicutto L., To T. Identifying individuals with physician diagnosed COPD in health administrative databases. COPD 2009, 6(5):388-394.
16. Goff D.C., Sullivan L.M., McEvoy J.P., Meyer J.M., Nasrallah H.A., Daumit G.L., Lamberti S., D'Agostino R.B., Stroup T.S., Davis S., Lieberman J.A. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr. Res. 2005, 80(1):45-53.
17. Goldner E.M., Hsu L., Waraich P., Somers J.M. Prevalence and incidence studies of schizophrenic disorders: a systematic review of the literature. Can. J. Psychiatry 2002, 47(9):833-843.
18. Hennekens C.H., Hennekens A.R., Hollar D., Casey D.E. Schizophrenia and increased risks of cardiovascular disease. Am. Heart J. 2005, 150(6):1115-1121.
19. Herlitz J., Karlson B., Hjalmarson A. Causes of death in patients presenting to hospital with symptoms suggestive of acute myocardial infarction: a one-year follow-up study with autopsy results. Coron. Artery Dis. 1994, 5(1):51-60.
20. Hux J.E., Ivis F., Flintoft V., Bica A. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002, 25(3):512-516.
21. Jorm A.F., Korten A.E., Jacomb P.A., Christensen H., Henderson S. Attitudes towards people with a mental disorder: a survey of the Australian public and health professionals. Aust. N. Z. J. Psychiatry 1999, 33(1):77-83.
22. Joukamaa M., Heliovaara M., Knekt P., Aromaa A., Raitasalo R., Lehtinen V. Mental disorders and cause-specific mortality. Br. J. Psychiatry 2001, 179:498-502.
23. Kilbourne A.M., Morden N.E., Austin K., Ilgen M., McCarthy J.F., Dalack G., Blow F.C. Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors. Gen. Hosp. Psychiatry 2009, 31(6):555-563.
24. Kisely S., Smith M., Lawrence D., Cox M., Campbell L.A., Maaten S. Inequitable access for mentally ill patients to some medically necessary procedures. CMAJ 2007, 176(6):779-784.
25. Kisely S., Campbell L.A., Wang Y. Treatment of ischaemic heart disease and stroke in individuals with psychosis under universal healthcare. Br. J. Psychiatry 2009, 195(6):545-550.
26. Krumholz H.M., Merrill A.R., Schone E.M., Schreiner G.C., Chen J., Bradley E.H., Wang Y., Lin Z., Straube B.M., Rapp M.T., Normand S.L., Drye E.E. Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ. Cardiovasc. Qual. Outcomes 2009, 2(5):407-413.
27. Laursen T.M., Munk-Olsen T., Agerbo E., Gasse C., Mortensen P.B. Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder. Arch. Gen. Psychiatry 2009, 66(7):713-720.
28. Lee D.S., Stitt A., Wang X., Yu J.S., Gurevich Y., Kingsbury K.J., Austin P.C., Tu J.V. Administrative hospitalization database validation of cardiac procedure codes. Med. Care 2011, (epub ahead of print).
29. Martens P., Fransoo R., McKeen N., Burland E., Jebaman i.L., Burchill C., De Coster C., Ekuma O., Prior H., Chateau D., Robinson R., Metge C. Patterns of Regional Mental Illness Disorder Diagnoses and Service Use in Manitoba: a Population-based Study 2004, Manitoba Centre for Health Policy, Winnipeg, MB.
30. McCreadie R.G. Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br. J. Psychiatry 2003, 183:534-539.
31. McEvoy J.P., Meyer J.M., Goff D.C., Nasrallah H.A., Davis S.M., Sullivan L., Meltzer H.Y., Hsiao J., Scott Stroup T., Lieberman J.A. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr. Res. 2005, 80(1):19-32.
32. Nasrallah H.A., Meyer J.M., Goff D.C., McEvoy J.P., Davis S.M., Stroup T.S., Lieberman J.A. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophr. Res. 2006, 86(1-3):15-22.
33. Newcomer J.W., Hennekens C.H. Severe mental illness and risk of cardiovascular disease. JAMA 2007, 298(15):1794-1796.
34. Reist C., Mintz J., Albers L.J., Jamal M.M., Szabo S., Ozdemir V. Second-generation antipsychotic exposure and metabolic-related disorders in patients with schizophrenia: an observational pharmacoepidemiology study from 1988 to 2002. J. Clin. Psychopharmacol. 2007, 27(1):46-51.
35. Ross J.S., Normand S.L., Wang Y., Ko D.T., Chen J., Drye E.E., Keenan P.S., Lichtman J.H., Bueno H., Schreiner G.C., Krumholz H.M. Hospital volume and 30-day mortality for three common medical conditions. N. Engl. J. Med. 2010, 362(12):1110-1118.
36. Saha S., Chant D., McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?. Arch. Gen. Psychiatry 2007, 64(10):1123-1131.
37. SAS SAS System, Version 9: Installation and Administration Information 2007.
38. The Johns Hopkins ACG System Published 2010. Accessed: August 26, 2011. http://www.acg.jhsph.org/index.php?option=com_content&view=article&id=46&Itemid=366.